Elena Plummer

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Global IRS-1 phosphorylation analysis in insulin resistance

Paul R. Langlais, Zhengping Yi, Jean Finlayson et al. · Diabetologia · 2011 · 67 citations · Full text

Insulin Resistance, Signal Transduction, Biochemistry +7

Glulisine Versus Human Regular Insulin in Combination With Glargine in Noncritically Ill Hospitalized Patients With Type 2 Diabetes

Christian Meyer, Anna Boron, Elena Plummer et al. · Diabetes Care · 2010 · 27 citations · Full text

Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus

Peter Emerson, Timon W. van Haeften, Walkyria de Paula Pimenta et al. · Metabolism · 2009 · 14 citations · Full text

Obesity, Metabolic Syndrome, Diabetes +9